22nd Jun 2015 07:00
SHIRE PLC - Holding(s) in Company – AmendmentSHIRE PLC - Holding(s) in Company – Amendment
PR Newswire
London, June 22
Holding(s) in Company – Amendment
June 22, 2015 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”)
As a result of erroneous information received by the Company relating to interests in its securities, specifically the number of shares/voting rights disposed of, this announcement replaces the original announcement released on June 18, 2015, at 16:38.
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Shire plc |
2. Reason for the notification | StateYes/No |
An acquisition or disposal of voting rights | Yes |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No |
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No |
An event changing the breakdown of voting rights | No |
Other (please specify): | No |
3. Full name of person(s) subject to the notification obligation: | FMR LLC |
4. Full name of shareholder(s) (if different from 3.): | See Section 9 |
5. Date of the transaction (and date on which the threshold is crossed or reached if different): | June 17, 2015 |
6. Date on which issuer notified: | June 19, 2015 |
7. Threshold(s) that is/are crossed or reached: | 5% |
8. Notified details: | ||||||||
A: Voting rights attached to shares | ||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous tothe triggeringtransaction | Resulting situation after the triggeringtransaction | ||||||
NumberofShares | NumberofVotingRights | Numberofshares | Number of votingrights | % of votingrights | ||||
Indirect | Direct | Indirect | Direct | Indirect | ||||
JE00B2QKY057 | 29,674,746 | 29,674,746 | 29,421,281 | 29,421,281 | 4.97 | |||
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financialinstrument | Expirationdate | Exercise/ConversionPeriod/ Date | Number of votingrights that may beacquired if the instrumentis exercised/converted | % of votingrights |
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights | |
Nominal | Delta | |||||
Total (A+B+C) | |
Number of voting rights | % of voting rights |
29,421,281 | 4.97 |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Proxy Voting:10. Name of the proxy holder: | FMR LLC |
11. Number of voting rights proxy holder will cease to hold: | 253,465 |
12. Date on which proxy holder will cease to hold voting rights: | June 17, 2015 |
13. Additional information: | None |
14. Contact name: | Sally-Ann Hatton |
15. Contact telephone number: | [email protected], 01737 837148 |
For further information please contact:
Investor Relations | ||
Sarah Elton-Farr | [email protected] | +44 1256 894157 |
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
http://www.shire.com/
Related Shares:
Shire